As children head back to school, two issues have climbed higher on their parents’ list of concerns: the role of social media and the internet in kids’ lives.
Novartis to seek approvals in two rare kidney diseases after positive Phase 3 trials
Novartis is building out its rare kidney disease portfolio with two batches of Phase 3 data at the European Renal Association conference, touting positive results
May 26, 2024